JP2014513036A5 - - Google Patents

Download PDF

Info

Publication number
JP2014513036A5
JP2014513036A5 JP2013536737A JP2013536737A JP2014513036A5 JP 2014513036 A5 JP2014513036 A5 JP 2014513036A5 JP 2013536737 A JP2013536737 A JP 2013536737A JP 2013536737 A JP2013536737 A JP 2013536737A JP 2014513036 A5 JP2014513036 A5 JP 2014513036A5
Authority
JP
Japan
Prior art keywords
dmf
diisopropylphosphorano
rucl
dimethylformamide
benzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013536737A
Other languages
English (en)
Other versions
JP2014513036A (ja
JP5945545B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013536737A priority Critical patent/JP5945545B2/ja
Priority claimed from JP2013536737A external-priority patent/JP5945545B2/ja
Publication of JP2014513036A publication Critical patent/JP2014513036A/ja
Publication of JP2014513036A5 publication Critical patent/JP2014513036A5/ja
Application granted granted Critical
Publication of JP5945545B2 publication Critical patent/JP5945545B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (1)

  1. 式:
    RuCl(L)(dmf) (V)
    [式中、Lは、1,2−ビス(2,5−ジイソプロピルホスホラノ)ベンゼンの光学活性体を;
    dmfは、N,N−ジメチルホルムアミドを;および、
    nは、1以上の整数を示す。]
    で表されるルテニウム錯体。
JP2013536737A 2011-02-17 2012-02-16 光学活性なジヒドロベンゾフラン誘導体の製造法 Expired - Fee Related JP5945545B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013536737A JP5945545B2 (ja) 2011-02-17 2012-02-16 光学活性なジヒドロベンゾフラン誘導体の製造法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011032610 2011-02-17
JP2011032610 2011-02-17
JP2013536737A JP5945545B2 (ja) 2011-02-17 2012-02-16 光学活性なジヒドロベンゾフラン誘導体の製造法
PCT/JP2012/054337 WO2012111849A1 (en) 2011-02-17 2012-02-16 Production method of optically active dihydrobenzofuran derivative

Publications (3)

Publication Number Publication Date
JP2014513036A JP2014513036A (ja) 2014-05-29
JP2014513036A5 true JP2014513036A5 (ja) 2015-04-02
JP5945545B2 JP5945545B2 (ja) 2016-07-05

Family

ID=45841559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013536737A Expired - Fee Related JP5945545B2 (ja) 2011-02-17 2012-02-16 光学活性なジヒドロベンゾフラン誘導体の製造法

Country Status (23)

Country Link
US (1) US8952185B2 (ja)
EP (1) EP2675774A1 (ja)
JP (1) JP5945545B2 (ja)
KR (1) KR20140015371A (ja)
CN (1) CN103492348A (ja)
AR (1) AR085252A1 (ja)
AU (1) AU2012218401A1 (ja)
BR (1) BR112013020634A2 (ja)
CA (1) CA2827271A1 (ja)
CL (1) CL2013002356A1 (ja)
CO (1) CO6761376A2 (ja)
CR (1) CR20130407A (ja)
DO (1) DOP2013000188A (ja)
EA (1) EA201391180A1 (ja)
EC (1) ECSP13012855A (ja)
IL (1) IL227879A0 (ja)
MA (1) MA34965B1 (ja)
MX (1) MX2013009526A (ja)
SG (1) SG192645A1 (ja)
TN (1) TN2013000347A1 (ja)
TW (1) TW201245169A (ja)
UY (1) UY33913A (ja)
WO (1) WO2012111849A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103145663B (zh) * 2013-03-01 2016-03-23 上海高准医药有限公司 (s)-2-(2,3-二氢苯并呋喃-3-基)乙酸衍生物,其制备方法及其在医药上的应用
CN104250239B (zh) * 2013-06-29 2016-09-07 山东轩竹医药科技有限公司 芳香多环羧酸衍生物
CN104370864B (zh) * 2013-08-14 2016-04-13 成都苑东生物制药股份有限公司 一种2-(6-羟基-2,3-二氢苯并呋喃-3-基)乙腈化合物和以该化合物制备tak-875药物的方法
EP3049396B1 (en) * 2013-09-26 2017-11-15 Boehringer Ingelheim International GmbH Process and intermediates for preparing indanyloxydihydrobenzofuranyl acetic acid derivatives as gpr40 agonists
IN2013MU03577A (ja) 2013-11-14 2015-07-31 Cadila Healthcare Ltd
WO2015084692A1 (en) 2013-12-04 2015-06-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
CN104177320B (zh) * 2014-08-27 2016-03-02 广东东阳光药业有限公司 一种脲取代联苯类化合物及其组合物及用途
BR112017019920B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
BR112017019918B1 (pt) * 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica
CN105418563B (zh) * 2015-12-28 2017-11-10 山东大学 Tak‑875类似物及其制备方法与应用
CN107543872B (zh) * 2016-06-29 2022-03-08 南京长澳医药科技有限公司 通过手性高效液相色谱法分离测定甲苯磺酸依度沙班水合物与其异构体杂质的方法
WO2018077699A1 (en) 2016-10-25 2018-05-03 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
US10919859B2 (en) 2017-01-26 2021-02-16 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
CN106977478B (zh) * 2017-04-21 2019-04-09 山东大学 一种2-(6-羟基-2,3-二氢苯并呋喃-3-基)乙酸甲酯的手性拆分方法
CR20200347A (es) 2018-02-13 2020-09-23 Gilead Sciences Inc Inhibidores pd-1/pd-l1
CN112041311B (zh) 2018-04-19 2023-10-03 吉利德科学公司 Pd-1/pd-l1抑制剂
KR20230159715A (ko) 2018-07-13 2023-11-21 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
AU2019366355B2 (en) 2018-10-24 2022-10-13 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
IL291985A (en) 2019-10-07 2022-06-01 Kallyope Inc gpr119 agonists
MX2022014505A (es) 2020-05-19 2022-12-13 Kallyope Inc Activadores de la ampk.
EP4172162A1 (en) 2020-06-26 2023-05-03 Kallyope, Inc. Ampk activators
CN114539168B (zh) * 2020-11-27 2023-11-17 武汉大学 一种合成Piragliatin及其类似物的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862562B1 (en) 1995-09-13 2001-07-04 Takeda Chemical Industries, Ltd. Benzoxazepine compounds, their production and use as lipid lowering agents
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
WO2002006234A1 (fr) 2000-07-17 2002-01-24 Takeda Chemical Industries, Ltd. Derives de sulfonate, procede de production et utilisation de ces derives
AU2003278600A1 (en) 2002-11-01 2004-05-25 Takeda Pharmaceutical Company Limited Agent for preventing or treating neuropathy
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
AU2003284596A1 (en) 2002-11-22 2004-06-18 Takeda Pharmaceutical Company Limited Imidazole derivative, process for producing the same, and use
CA2527691C (en) 2003-05-30 2013-01-22 Takeda Pharmaceutical Company Limited Condensed ring compound
US7534887B2 (en) 2003-09-30 2009-05-19 Takeda Pharmaceutical Company Limited Thiazoline derivative and use of the same
US7820673B2 (en) 2003-12-17 2010-10-26 Takeda Pharmaceutical Company Limited Urea derivative, process for producing the same, and use
TW200523247A (en) 2003-12-25 2005-07-16 Takeda Pharmaceutical 3-(4-benzyloxyphenyl) propanoic acid derivatives
WO2005063725A1 (ja) 2003-12-26 2005-07-14 Takeda Pharmaceutical Company Limited フェニルプロパン酸誘導体
US7786165B2 (en) 2004-03-15 2010-08-31 Takeda Pharmaceutical Company Limited Aminophenylpropanoic acid derivative
JP4859665B2 (ja) 2004-03-30 2012-01-25 武田薬品工業株式会社 アルコキシフェニルプロパン酸誘導体
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
GB0428101D0 (en) * 2004-12-23 2005-01-26 Astrazeneca Ab Chemical Processes & Intermediates
US8957070B2 (en) 2005-04-20 2015-02-17 Takeda Pharmaceutical Company Limited Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
EP1911738A4 (en) 2005-07-29 2009-12-16 Takeda Pharmaceutical PHENOXYALKANSÄUREVERBINDUNG
US8153694B2 (en) 2005-07-29 2012-04-10 Takeda Pharmaceutical Company Limited Cyclopropanecarboxylic acid compound
US20080009530A1 (en) 2005-08-10 2008-01-10 Hidenori Abe Therapeutic Agent for Diabetes
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
EP2743268A3 (en) 2006-06-27 2014-10-08 Takeda Pharmaceutical Company Limited Fused cyclic compounds as GPR40 receptor modulators
EP2298772A1 (en) 2006-10-18 2011-03-23 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds
US7652133B2 (en) 2006-10-19 2010-01-26 Takeda Pharmaceutical Company Limited Indole compound
JPWO2008093639A1 (ja) 2007-01-29 2010-05-20 武田薬品工業株式会社 ピラゾール化合物
WO2008099794A1 (en) 2007-02-09 2008-08-21 Takeda Pharmaceutical Company Limited Fused ring compounds as partial agonists of ppar-gamma
US8455661B2 (en) 2007-02-18 2013-06-04 University Of Florida Research Foundation, Inc. Catalysts containing N-heterocyclic carbenes for enantioselective synthesis
EP2149550A4 (en) 2007-04-27 2010-08-11 Takeda Pharmaceutical HETEROCYCLIC COMPOUND WITH FIVE NITROGEN CHAINS
EP2157859A4 (en) 2007-06-19 2011-01-12 Takeda Pharmaceutical INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE
EP2440541A1 (en) 2009-06-09 2012-04-18 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
JP5129209B2 (ja) 2009-08-03 2013-01-30 ゴールドフラッグ株式会社 ブラジャー及び該ブラジャー付き下着とこれをインナーとしたアウター

Similar Documents

Publication Publication Date Title
JP2014513036A5 (ja)
LTPA2019504I1 (lt) Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
JP2011506530A5 (ja)
JP2013514381A5 (ja)
JP2012143233A5 (ja)
JP2011527428A5 (ja)
JP2010219032A5 (ja)
JP2010538767A5 (ja)
JP2015512729A5 (ja)
JP2011508438A5 (ja)
JP2013500200A5 (ja)
JP2015504870A5 (ja)
JP2015518492A5 (ja)
JP2013540702A5 (ja)
JP2013522131A5 (ja)
JP2011246422A5 (ja)
JP2014508179A5 (ja)
JP2015030781A5 (ja)
JP2014520066A5 (ja)
JP2012043586A5 (ja)
JP2012250569A5 (ja)
JP2012006888A5 (ja)
JP2013506570A5 (ja)
JP2011249271A5 (ja)
JP2014048562A5 (ja)